229. Autoimmune pulmonary alveolar proteinosis Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 44 / Drugs : 22 - (DrugBank : 7) / Drug target genes : 3 - Drug target pathways : 14
Autoimmune pulmonary alveolar proteinosis and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 229 | Autoimmune pulmonary alveolar proteinosis | - |
| 6 | Parkinson disease | 3.000 |
| 46 | Malignant rheumatoid arthritis | 3.000 |
| 96 | Crohn disease | 3.000 |
| 97 | Ulcerative colitis | 3.000 |
| 94 | Primary sclerosing cholangitis | 1.404 |
| 285 | Fanconi anemia | 1.378 |
| 41 | Giant cell arteritis | 1.374 |
| 93 | Primary biliary cholangitis | 1.371 |
| 60 | Aplastic anemia | 1.365 |
| 222 | Primary nephrotic syndrome | 1.355 |
| 65 | Primary immunodeficiency | 1.348 |
| 299 | Cystic fibrosis | 1.347 |
| 86 | Pulmonary arterial hypertension | 1.347 |
| 49 | Systemic lupus erythematosus | 1.345 |
| 13 | Multiple sclerosis/Neuromyelitis optica | 1.338 |
| 52 | Mixed connective tissue disease | 1.000 |